Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Terminated 6

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 16Thoracic 6Lymphoid 6Genitourinary 6Gastrointestinal 6Tumor-Agnostic 2Sarcoma 2Gynecologic 2Endocrine 2Dermatologic 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Mesothelioma, Malignant 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × antineoplaston AS 2-1 × Thoracic × Clear all
NCT00003508 2021-04-27

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Burzynski Research Institute

Phase 2 Terminated
8 enrolled 5 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00003492 2020-12-16

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
9 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003497 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00003491 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
17 enrolled
Thoracic

Lung Neoplasms

NCT00003495 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
7 enrolled
Thoracic

Lung Neoplasms

NCT00003496 2017-09-28

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

Burzynski Research Institute

Phase 2 Terminated
4 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡